Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | CDC25A | P30304 | 1/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | FABP2 | P12104 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29367513 | 1.00 | CA12 (0.36) | CA12CA1CA2CA9GABRA1 | |
| SCHEMBL15608644 | 0.98 | CA12 (0.35) | CA12CA1CA2CA9GABRA1 | |
| Ammonia Solution, Strong SCHEMBL28410562 | 0.98 | CA12 (0.35) | CA12CA1CA2CA9GABRA1 | |
| Hydrochloric Acid SCHEMBL15609201 | 0.96 | CA12 (0.34) | CA12CA1CA2CA9GABRA1 | |
| SCHEMBL11513836 | 0.96 | CA12 (0.38) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL15609202 | 0.94 | CA12 (0.33) | CA12CA1CA2CA9GABRA1 | |
| Phosphoric Acid SCHEMBL3912754 | 0.89 | PTPN5 (0.38) | CA12CA1CA2CA9PTGS1 | |
| SCHEMBL6838848 | 0.89 | CDC25A (0.41) | CDC25ACDC25BESR2PTGS1MEN1 | |
| SCHEMBL11326459 | 0.87 | MEN1 (0.37) | HSP90AA1MEN1KMT2ALMNAMAPT | |
| SCHEMBL8135460 | 0.84 | GCGR (0.35) | CA12CA1CA2CA9GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1899 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115850254-B | Synthesis method of pyrifos | 山东润博生物科技有限公司 | 2024-06-25 | — | — | CN | claimed |
| EP-4359401-A1 | PROCESS FOR PREPARING EGFR INHIBITORS | Blueprint Medicines Corporation (US) | 2024-05-01 | — | — | EP | claimed |
| CN-117430552-A | Near infrared two-region fluorescent dye molecule diphenylamine acridine and preparation method and application thereof | 复旦大学 | 2024-01-23 | — | — | CN | claimed |
| CN-117384129-A | Impurity compound, preparation method and application thereof | 浙江九洲药业股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-116724021-A | Synthesis of polyfluorinated aryl and heteroaryl carboxamides | 巴斯夫欧洲公司 | 2023-09-08 | — | — | CN | claimed |
| CN-116470045-A | Nitrogen-containing conjugated lignin lithium-sulfur battery positive electrode material and preparation method thereof | 东北林业大学 | 2023-07-21 | — | — | CN | claimed |
| WO-2022271801-A1 | PROCESS FOR PREPARING EGFR INHIBITORS | BLUEPRINT MEDICINES CORPORATION (US) | 2022-12-29 | — | — | WO | claimed |
| CN-115093547-A | Bicarbazole polymer p-BCz-Ph and synthetic method and application thereof | 中盐金坛盐化有限责任公司 | 2022-09-23 | — | — | CN | claimed |
| CN-115052855-A | Preparation method of amide compound, crystal form and salt thereof | 昊运股份有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-110372524-B | Triphenylamine organic hole transport material with binaphthyl amine as mother core, and synthesis and application thereof | 天津理工大学 | 2022-08-30 | — | — | CN | claimed |
| US-20090042945-A1 | Benzo[d]isoxazol-3-yl-amine Compounds and Their Use as Vanilloid Receptor Ligands | GRUENENTHAL GMBH (DE) | 2009-02-12 | — | — | US | claimed |
| US-5847040-A | Lower alkyl biphenyls as plasticizers for polyurethane | KOCH INDUSTRIES, INC. (US) | 1998-12-08 | — | — | US | claimed |
| US-5696184-A | EPOXY POLYMER CONTAINING DIISOPROPYLBIPHENYL AND/OR TRIISOPROPYLBIPHENYL; INCREASED FLEXIBILITY AND TOUGHNESS | KOCH INDUSTRIES, INC. (US) | 1997-12-09 | — | — | US | claimed |
| EP-0601690-B1 | Solvent for use in carbonless paper, comprising diisopropylbiphenyl and triisopropylbiphenyl, and products utilising the same | KOCH IND INC (US) | 1997-04-23 | — | — | EP | claimed |
| US-5489646-A | CAN USE HIGH LOAD LEVELS | KOCH INDUSTRIES, INC. (US) | 1996-02-06 | — | — | US | claimed |
| US-5458974-A | Low odor carbonless paper solvent | KOCH INDUSTRIES, INC. (US) | 1995-10-17 | — | — | US | claimed |
| EP-0671124-A1 | Solid biocidal concentrates | ROHM AND HAAS COMPANY (US) | 1995-09-13 | — | — | EP | claimed |
| US-5430046-A | Containing a melting point depressant which is miscible; repeatedly meltable, solidifiable | ROHM AND HAAS COMPANY (US) | 1995-07-04 | — | — | US | claimed |
| EP-0601690-A1 | Solvent for use in carbonless paper, comprising diisopropylbiphenyl and triisopropylbiphenyl, and products utilising the same | KOCH INDUSTRIES, INC. (US) | 1994-06-15 | — | — | EP | claimed |
| US-5318940-A | Writing or printing recording sheet with coating having microcapsules containing chromogen and odorless solvent | KOCH INDUSTRIES, INC. (US) | 1994-06-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042945-A1 | Benzo[d]isoxazol-3-yl-amine Compounds and Their Use as Vanilloid Receptor Ligands | TRPV1, TRPV3, TRPV5 | CA12 2549/4885CA1 3307/4885CA2 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.